Concepedia

Christopher Nardo

CN

10

Publications

2.4K

Citations

10

H-Index

1995

Active since

Affiliations

Allergan (United States)(Current)

University of North Carolina at Chapel Hill

Allergan (United Kingdom)

University of Toronto

Response Technologies (United States)

Christopher Nardo is an author at Allergan (United States) specializing in medicine, cardiovascular disease, and cardiovascular reactivity.

Top concepts

Publications per year

1995–2017

10

Publications

10

Non–Insulin-Dependent Diabetes Mellitus and Fasting Glucose and Insulin Concentrations Are Associated With Arterial Stiffness Indexes

Veikko Salomaa, Ward A. Riley, Jeremy D. Kark et al. · Circulation · 1995 · 578 citations

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Christopher R. Chapple, Karl‐Dietrich Sievert, Scott MacDiarmid et al. · European Urology · 2013 · 401 citations

, , +5

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

Victor W. Νitti, Roger R. Dmochowski, Sender Herschorn et al. · The Journal of Urology · 2012 · 399 citations

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

Victor W. Νitti, Roger R. Dmochowski, Sender Herschorn et al. · The Journal of Urology · 2016 · 328 citations

Orthostatic hypotension and the incidence of coronary heart disease: the atherosclerosis risk in communities study

K. M. Rose, Herman A. Tyroler, Christopher Nardo et al. · American Journal of Hypertension · 2000 · 244 citations · Full text

Rows per page

1–5 of 10